Few psych drugs from past decade are on HCPs' radars: survey
Ask a healthcare professional to name a psychiatric medicine and chances are they’ll say a brand approved at least 10 years ago. That finding, which comes from a ZoomRx survey, points to the challenge facing new market entrants as they try to wrestle mindshare from incumbents through marketing.
Ask a healthcare professional to name a psychiatric medicine and chances are they’ll say a brand approved at least 10 years ago. That finding, which comes from a ZoomRx survey, points to the challenge facing new market entrants as they try to wrestle mindshare from incumbents through marketing.
